Goldfinch Biopharma Company
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
Technology:
Neurological Disorders
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2015
Employees Number:
11-50
Funding Status:
Early Stage Venture
Total Funding:
210000000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership